Ipca Laboratories Ltd. | Large-cap | Healthcare
₹1,331.70
-0.95%
| Ipca Laboratories Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 89.4B
Gross Profit 61.6B 68.92%
Operating Income 13.3B 14.86%
Net Income 7.9B 8.78%
EPS (Diluted) ₹35.14

Balance Sheet Metrics

Total Assets 117.6B
Total Liabilities 33.7B
Shareholders Equity 83.9B
Debt to Equity 0.40

Cash Flow Metrics

Operating Cash Flow 9.1B
Free Cash Flow 5.5B

Revenue & Profitability Trend

Ipca Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 89.4B 76.2B 62.1B 57.7B 53.7B
Cost of Goods Sold 27.8B 27.3B 24.1B 21.1B 18.0B
Gross Profit 61.6B 49.0B 38.0B 36.6B 35.6B
Operating Expenses 24.5B 18.5B 14.5B 11.4B 9.9B
Operating Income 13.3B 9.3B 7.0B 10.6B 13.2B
Pre-tax Income 11.3B 8.4B 7.5B 11.4B 13.9B
Income Tax 3.4B 3.1B 2.5B 2.2B 2.4B
Net Income 7.9B 5.2B 4.8B 8.9B 11.4B
EPS (Diluted) ₹35.14 ₹21.57 ₹18.58 ₹34.85 ₹45.01

Income Statement Trend

Ipca Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 59.7B 55.4B 51.9B 44.6B 34.4B
Non-Current Assets 57.9B 55.6B 34.4B 31.7B 26.3B
Total Assets 117.6B 111.0B 86.3B 76.2B 60.7B
Liabilities
Current Liabilities 23.9B 23.6B 18.1B 14.7B 11.6B
Non-Current Liabilities 9.9B 10.2B 9.1B 6.2B 1.9B
Total Liabilities 33.7B 33.7B 27.1B 20.8B 13.5B
Equity
Total Shareholders Equity 83.9B 77.3B 59.2B 55.4B 47.2B

Balance Sheet Composition

Ipca Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 11.3B 8.4B 7.5B 11.4B 13.9B
Operating Cash Flow 9.1B 8.2B 7.9B 9.4B 10.5B
Investing Activities
Capital Expenditures -7.7B -4.0B -4.6B -4.8B -3.6B
Investing Cash Flow -9.0B -14.0B -7.4B -9.0B -5.1B
Financing Activities
Dividends Paid -1.0B -507.4M -1.0B -1.0B -1.0B
Financing Cash Flow -1.9B -4.1B 5.6B 4.4B -2.9B
Free Cash Flow 5.5B 5.3B 3.1B 3.8B 7.3B

Cash Flow Trend

Ipca Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 46.02
Forward P/E 28.00
Price to Book 4.90
Price to Sales 3.85
PEG Ratio 28.00

Profitability Ratios

Profit Margin 8.25%
Operating Margin 14.63%
Return on Equity 9.74%
Return on Assets 7.26%

Financial Health

Current Ratio 2.63
Debt to Equity 16.25
Beta 0.24

Per Share Data

EPS (TTM) ₹29.12
Book Value per Share ₹273.55
Revenue per Share ₹352.41

Financial data is updated regularly. All figures are in the company's reporting currency.